Artesunate

Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Artesunate is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • FDA approved for the treatment of severe malaria in adults and pediatric patients (May 2020)
    • Artesunate (as a single agent) is available for emergency use in the U.S. (contact CDC) for severe falciparum malaria.
    • Until drug supply is adequate in the U.S., the CDC remains the point of contact to obtain the drug.

NON-FDA APPROVED USES

  • Mild to moderate malaria falciparum.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • FDA approved for the treatment of severe malaria in adults and pediatric patients (May 2020)
    • Artesunate (as a single agent) is available for emergency use in the U.S. (contact CDC) for severe falciparum malaria.
    • Until drug supply is adequate in the U.S., the CDC remains the point of contact to obtain the drug.

NON-FDA APPROVED USES

  • Mild to moderate malaria falciparum.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: July 3, 2020